Saturday 7 November 2026
Export VTR’s income statement to Excel — free account
Ventas, Inc.
VTR Real Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −6.50%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
88.88
0.16
−0.18%
Follow VTR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
140.69 | 146.04 | 161.45 | 157.18 |
P/S ratio |
6.04 | 6.35 | 6.75 | 6.44 | |
P/FCF ratio |
27.45 | 29.01 | 31.11 | 30.02 | |
P/Operating CF |
74.66 | 98.69 | 78.07 | 89.25 | |
P/B ratio |
2.80 | 2.95 | 2.96 | 2.76 | |
Price to Tangible BV |
3.05 | 3.21 | 3.18 | 2.95 | |
EV/Sales |
8.13 | 8.36 | 8.68 | 8.24 | |
EV/EBITDA |
21.28 | 22.21 | 23.26 | 22.29 | |
EV/Operating CF |
28.81 | 29.80 | 31.04 | 29.23 | |
EV/FCF |
36.98 | 38.19 | 40.03 | 38.41 | |
Quick Ratio |
0.67 | 0.25 | 0.44 | 0.15 | |
Current Ratio |
0.67 | 0.25 | 0.44 | 0.43 | |
Net Debt/EBITDA |
20.75 | 20.68 | 19.38 | 17.95 | |
Debt/Assets |
47.16% | 45.22% | 42.78% | 40.61% | |
Debt/Equity |
1.03 | 0.95 | 0.86 | 0.78 | |
Asset Turnover |
0.22 | 0.23 | 0.23 | 0.24 | |
Operating CF/Net income |
6.72 | 7.06 | 7.89 | 7.49 | |
Capex/Depreciation |
(0.39) | (0.19) | (0.25) | (0.32) | |
Interest Coverage |
1.52 | 1.33 | 1.45 | 1.44 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.62% | 3.79% | 2.72% | 2.60% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.03 | |
Share Based Compensation of Revenue |
0.40% | 1.50% | 0.31% | 0.32% | |
Graham Net Nets |
(0.40) | (0.36) | (0.33) | (0.32) | |
Graham Number |
18.50 | 18.68 | 19.28 | 19.38 | |
Earnings Yield |
0.71% | 0.68% | 0.62% | 0.64% | |
Free Cash Flow Yield |
3.64% | 3.45% | 3.21% | 3.33% | |
Revenue per Share |
3.44 | 3.48 | 3.54 | 3.56 | |
Operating CF per Share |
1.04 | 0.83 | 1.14 | 0.95 | |
Capex per Share |
(0.30) | (0.15) | (0.21) | (0.28) | |
Free Cash Flow per Share |
0.73 | 0.68 | 0.93 | 0.67 | |
Cash per Share |
1.73 | 0.42 | 0.46 | 0.45 | |
Shareholders Equity per Share |
27.66 | 27.68 | 30.05 | 30.86 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
27.66 | 27.68 | 30.05 | 30.86 | |
Free Cash Flow |
333.95 | 321.64 | 454.72 | 345.06 | |
Working Capital |
(453.87) | (1,016.90) | (831.72) | (895.53) | |
Capital Expenditures |
(137.71) | (72.96) | (101.83) | (144.55) | |
Net Current Asset Value |
(14,076.09) | (14,165.88) | (14,293.12) | (14,093.80) | |
EV/EBIT |
55.32 | 59.04 | 62.33 | 61.62 | |
Capex to Sales |
0.09 | 0.04 | 0.06 | 0.08 | |
Price to Operating Income |
41.07 | 44.85 | 48.43 | 48.16 | |
| Other line items | |||||
Average Receivables |
144.36 | 141.12 | 310.03 | — | |
Average Payables |
1,196.56 | 1,184.10 | 1,240.83 | 1,348.09 | |
Average Assets |
26,889.43 | 26,859.42 | 28,065.42 | 28,775.54 | |
Average Common Equity |
11,707.71 | 12,354.06 | 13,147.51 | 14,141.71 |
Columns are period end dates · fundamentals updated 6 Nov 2026